drugset / Trial / NCT07230509

Pancreatic Parenchymal Injection of N-butyl-2-cyanoacrylate

NCT07230509

Phase 2 Recruiting 90 enrolled Minia University
RandomizedParallel-groupSingle-blindPrevention

Summary

This randomized controlled trial investigates the safety and efficacy of injecting N-butyl-2- cyanoacrylate (Histoacryl®) into the pancreatic parenchyma during pancreaticoduodenectomy (PD) to enhance the security of the pancreaticojejunostomy (PJ) anastomosis and reduce postoperative pancreatic fistula (POPF) rates.

Timeline

Start
2025-12-01
Primary completion
2027-12-01
Completion
2027-12-20

Drugs

EvaluationDrugModalityDoseRoute
Subject N-butyl-2-cyanoacrylate Other / unclassified 0.2 ml Other
Subject N-butyl-2-cyanoacrylate Other / unclassified 0.5 ml Other
Subject N-butyl-2-cyanoacrylate Other / unclassified 0.6 ml Other
Background lipiodol Unknown Other